The risks of medical innovation
Subtitle: risk perception and assessment in historical context
By: [edited by] Thomas Schlich and Ulrich Tröhler.
Contributors: Schlich, Thomas.; Tröhler, Ulrich, 1943-
Series: Routledge studies in the social history of medicine
Publisher: Routledge
Published: 2005
Place of publication: London; New York
Language: eng
Number of pages: 291
Subjects: Medical innovations; Health risk assessment; Risk perception; Biomedical Technology -- trends; History of Medicine; History, Modern; Public Opinion; Risk Assessment -- trends; Technology Assessment, Biomedical -- trends
Notes: Includes bibliographical references.
Table of contents: title: Risk and medical innovation: a historical perspective / Thomas Schlich; title: To assess and to improve: practitioners' approaches to doubts linked with medical innovations 1720-1920 / Ulrich Tröhler; title: Anaesthesia and the evaluation of surgical risk in mid-nineteenth century Britain / Ian Burney; title: Redemption, danger, and risk: the history of anti-bacterial chemotherapy and the transformation of tuberculin / Christoph Gradmann; title: "As safe as milk or sugar water": perceptions of risks and benefits of the BCG vaccine in the 1920s and 1930s in France and Germany / Christian Bonah; title: From danger to risk: the perception and regulation of X-rays in Switzerland 1896-1970 / Monika Dommann; title: The population as patient: Alice Stewart and the controversy over low-level radiation in the 1950s / Sarah Dry; title: To treat or not to treat: drug research and the changing nature of essential hypertension / Carsten Timmermann; title: Hormones at risk: cancer and the medical uses of industrially-produced sex steroids in Germany, 1930-1960 / Jean-Paul Gaudillière; title: Assessment and medical authority in operative fracture care in the 1960 and 1970s / Thomas Schlich; title: Assessing the risk and safety of the pill: maternal mortality and the pill / Lara Marks; title: Addressing uncertainties: the conceptualisation of brain death in Switzerland 1960-2000 / Silke Bellanger and Aline Steinbrecher; title: Risk on trial: the interaction of innovation and risk in cancer clinical trials / Alberto Cambrosio and Peter Keating; title: Biorisk: interleukin-2 from laboratory to market in the United States and Germany / Arthur Daemmrich; title: The redemption of thalidomide: standardizing the risk of birth defects / Stefan Timmermans and Valerie Leiter.